We offer a validated proteomics platform using 268 million probes per sample, it detects challenging protein changes like post-translational modifications and mis-folding. Our platform enhances machine learning analysis for clinical trials, product repositioning, pharmacokinetics, off-target binding, and companion diagnostics. We can support your drug discovery programs.
Membres
NeoVentures Biotechnology Europe